Literature DB >> 9425667

Ion channels in the immune system as targets for immunosuppression.

M D Cahalan1, K G Chandy.   

Abstract

The discovery of a diverse and unique subset of ion channels in T lymphocytes has led to a rapidly growing body of knowledge about their functional roles in the immune system. Potent and specific blockers have provided molecular tools to probe channel structure-function relations and to elucidate the involvement of K+, Ca2+, and Cl- channels in T-cell activation and cell volume regulation. Recent advances in analyzing Kv1.3 channel structure-function relationships have defined binding sites for channel blockers, which have now been shown to be effective in suppressing T-cell function in vivo. Ion channels may provide excellent pharmaceutical targets for modulating immune system function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9425667     DOI: 10.1016/s0958-1669(97)80130-9

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  31 in total

1.  UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation.

Authors:  D C Hanson; A Nguyen; R J Mather; H Rauer; K Koch; L E Burgess; J P Rizzi; C B Donovan; M J Bruns; P C Canniff; A C Cunningham; K A Verdries; E Mena; J C Kath; G A Gutman; M D Cahalan; S Grissmer; K G Chandy
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  Colocalization and nonrandom distribution of Kv1.3 potassium channels and CD3 molecules in the plasma membrane of human T lymphocytes.

Authors:  G Panyi; M Bagdány; A Bodnár; G Vámosi; G Szentesi; A Jenei; L Mátyus; S Varga; T A Waldmann; R Gáspar; S Damjanovich
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

3.  Block of the lymphocyte K(+) channel mKv1.3 by the phenylalkylamine verapamil: kinetic aspects of block and disruption of accumulation of block by a single point mutation.

Authors:  R J Röbe; S Grissmer
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

4.  Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells.

Authors:  G Panyi; G Vámosi; Z Bacsó; M Bagdány; A Bodnár; Z Varga; R Gáspár; L Mátyus; S Damjanovich
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

Review 5.  Role of membrane potential in the regulation of cell proliferation and differentiation.

Authors:  Sarah Sundelacruz; Michael Levin; David L Kaplan
Journal:  Stem Cell Rev Rep       Date:  2009-06-27       Impact factor: 5.739

Review 6.  K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

Authors:  Heike Wulff; Boris S Zhorov
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

7.  Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.

Authors:  C Beeton; H Wulff; J Barbaria; O Clot-Faybesse; M Pennington; D Bernard; M D Cahalan; K G Chandy; E Béraud
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 8.  Novel therapies for memory cells in autoimmune diseases.

Authors:  P Bhargava; P A Calabresi
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

Review 9.  Voltage-dependent K(+) channels in pancreatic beta cells: role, regulation and potential as therapeutic targets.

Authors:  P E MacDonald; M B Wheeler
Journal:  Diabetologia       Date:  2003-06-27       Impact factor: 10.122

10.  Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences.

Authors:  Núria Villalonga; Miren David; Joanna Bielanska; Rubén Vicente; Núria Comes; Carmen Valenzuela; Antonio Felipe
Journal:  J Gen Physiol       Date:  2010-02       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.